D. Bareford

6.3k total citations · 1 hit paper
83 papers, 4.4k citations indexed

About

D. Bareford is a scholar working on Genetics, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, D. Bareford has authored 83 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Genetics, 32 papers in Hematology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in D. Bareford's work include Hemoglobinopathies and Related Disorders (23 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (22 papers) and Blood properties and coagulation (17 papers). D. Bareford is often cited by papers focused on Hemoglobinopathies and Related Disorders (23 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (22 papers) and Blood properties and coagulation (17 papers). D. Bareford collaborates with scholars based in United Kingdom, Denmark and United States. D. Bareford's co-authors include Anthony R. Green, Claire Harrison, Peter J. Campbell, Bridget S. Wilkins, John T. Reilly, Keith Wheatley, Georgina Buck, Wendy N. Erber, Clare East and Gregory Y.H. Lip and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

D. Bareford

83 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hydroxyurea Compared with Anagrelide in High-Risk Essential Thrombocythemia

2005 610 citations Claire Harrison, Peter J. Campbell et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Bareford United Kingdom	31	2.8k	2.0k	1.6k	936	406	83	4.4k
Massimo Breccia Italy	38	2.6k 0.9×	4.1k 2.0×	1.7k 1.0×	1.1k 1.2×	176 0.4×	403	5.6k
Khaled M. Musallam Lebanon	42	4.2k 1.5×	4.2k 2.1×	429 0.3×	193 0.2×	558 1.4×	173	6.7k
Anders Wåhlin Sweden	30	1.1k 0.4×	2.5k 1.2×	1.3k 0.8×	161 0.2×	76 0.2×	121	3.9k
Bart J. Biemond Netherlands	30	1.4k 0.5×	2.4k 1.2×	982 0.6×	81 0.1×	262 0.6×	126	3.7k
Andrew Mumford United Kingdom	38	871 0.3×	3.0k 1.5×	674 0.4×	205 0.2×	949 2.3×	137	5.0k
Christian Datz Austria	43	909 0.3×	1.4k 0.7×	877 0.5×	478 0.5×	320 0.8×	176	6.3k
W. Kline Bolton United States	32	687 0.2×	1.2k 0.6×	528 0.3×	231 0.2×	461 1.1×	81	4.6k
Jeffrey D. Greenberg United States	41	587 0.2×	1.3k 0.7×	415 0.3×	4.0k 4.2×	385 0.9×	144	5.4k
M. Greaves United Kingdom	39	354 0.1×	2.7k 1.3×	288 0.2×	912 1.0×	1.3k 3.2×	117	5.4k
Steve Kitchen United Kingdom	28	461 0.2×	2.3k 1.2×	246 0.2×	311 0.3×	600 1.5×	92	3.8k

Countries citing papers authored by D. Bareford

Since Specialization

Citations

This map shows the geographic impact of D. Bareford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Bareford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Bareford more than expected).

Fields of papers citing papers by D. Bareford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Bareford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Bareford. The network helps show where D. Bareford may publish in the future.

Co-authorship network of co-authors of D. Bareford

This figure shows the co-authorship network connecting the top 25 collaborators of D. Bareford. A scholar is included among the top collaborators of D. Bareford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Bareford. D. Bareford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bareford, D., et al.. (2009). Colonic carcinoma presenting as repeated episodes of enterobacter septicaemia during induction of remission in acute myeloblastic leukaemia. BMJ. 339(nov02 2). b4027–b4027. 2 indexed citations

Keidan, A. J. & D. Bareford. (2008). Recurrence of neutropenia associated with splenunculus. Clinical & Laboratory Haematology. 12(4). 461–464. 1 indexed citations

Blann, Andrew D., et al.. (2007). Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotype. Journal of Thrombosis and Thrombolysis. 25(2). 185–189. 15 indexed citations

Chakrabarti, Suparno & D. Bareford. (2007). A survey on patient perception of reduced-intensity transplantation in adults with sickle cell disease. Bone Marrow Transplantation. 39(8). 447–451. 48 indexed citations

Smellie, W S A, Cliodna McNulty, Lynn Hirschowitz, et al.. (2006). Best practice in primary care pathology: review 2: Figure 1. Journal of Clinical Pathology. 59(2). 113–120. 16 indexed citations

Smellie, W S A, et al.. (2006). Best practice in primary care pathology: review 3. Journal of Clinical Pathology. 59(8). 781–789. 55 indexed citations

Campbell, Peter J., Linda M. Scott, Georgina Buck, et al.. (2005). Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study. The Lancet. 366(9501). 1945–1953. 473 indexed citations

Bareford, D., et al.. (2005). Blood lead levels in iron-deficient and noniron-deficient adults. Clinical & Laboratory Haematology. 27(2). 105–109. 11 indexed citations

Bareford, D., et al.. (2005). Remission induction in a Jehovah's Witness patient with acute myeloid leukaemia using gemtuzumab ozogamicin. Transfusion Medicine. 15(5). 445–448. 5 indexed citations

10.

Blann, Andrew D., et al.. (2003). Platelet activation and endothelial cell dysfunction in sickle cell disease is unrelated to reduced antioxidant capacity. Blood Coagulation & Fibrinolysis. 14(3). 255–259. 28 indexed citations

11.

Adeyoju, Adebanji, Adebayo Olujohungbe, J.A. Morris, et al.. (2002). Priapism in sickle‐cell disease; incidence, risk factors and complications – an international multicentre study. British Journal of Urology. 90(9). 898–902. 184 indexed citations

12.

Blann, Andrew D., et al.. (2002). Reduced vitamin E antioxidant capacity in sickle cell disease is related to transfusion status but not to sickle crisis. American Journal of Hematology. 69(2). 144–146. 16 indexed citations

13.

Blann, Andrew D., Paul Harrison, Mark A. Lumley, et al.. (2002). Increased non‐transferrin bound iron in plasma‐depleted SAG‐M red blood cell units. Vox Sanguinis. 82(3). 122–126. 19 indexed citations

14.

Matutes, Estella, Graham P. Taylor, James D. Cavenagh, et al.. (2001). Interferon α and zidovudine therapy in adult T‐cell leukaemia lymphoma: response and outcome in 15 patients. British Journal of Haematology. 113(3). 779–784. 73 indexed citations

15.

Blann, Andrew D., et al.. (2001). Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor. Blood Coagulation & Fibrinolysis. 12(1). 43–50. 82 indexed citations

16.

Bain, Barbara J., R. Amos, D. Bareford, et al.. (1998). THE LABORATORY DIAGNOSIS OF HAEMOGLOBINOPATHIES. British Journal of Haematology. 101(4). 783–792. 102 indexed citations

17.

Lip, Gregory Y.H., Peck Lin Lip, D. Bareford, et al.. (1996). Effects of introducing ultra-low dose wartarin and aspirin on fibrin D-dimer and beta-thromboglobulin as markers of intravascular thrombogenesis and platelet activation in chronic atrial fibrillation. Journal of the American College of Cardiology. 27(2). 409–409. 1 indexed citations

18.

Lim, Seah H., Adrian C. Newland, A.J. Bell, et al.. (1992). Continuous intravenous infusion of high-dose recombinant interleukin-2 for acute myeloid leukaemia — a phase II study. Cancer Immunology Immunotherapy. 34(5). 337–342. 50 indexed citations

19.

Lim, Hoong Sern, B. J. Boughton, & D. Bareford. (1989). Thrombocytopenia Following Routine Blood Transfusion: Micro‐Aggregate Blood Filters Prevent Worsening Thrombocytopenia in Patients with Low Platelet Counts. Vox Sanguinis. 56(1). 40–41. 14 indexed citations

20.

Bareford, D., DH Pamphilon, & Dorothy Barnard. (1984). Nonaggressive combination chemotherapy for resistant immunocytoma.. PubMed. 68(7-8). 1033–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact